Background: New treatment modalities are urgently needed for patients with COVID-19. The
World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or …

Background We aimed to identify a human immunodeficiency virus (HIV)–related microbiota
signature, independent of sexual preferences and demographic confounders, in order to …

Background Although coronavirus disease 2019 (COVID‐19) is primarily a respiratory
infection, mounting evidence suggests that the gastrointestinal tract is involved in the disease, …

HIV infection and type 2 diabetes are associated with altered gut microbiota, chronic
inflammation, and increased cardiovascular risk. We aimed to investigate the combined effect of …

Objectives: HIV infection is associated with increased risk of coronary heart disease beyond
that explained by traditional risk factors, and altered gut microbiota has been proposed as a …

Methods: A cross-sectional study was conducted in two rural communities in Quang Tri,
Vietnam. A total of 1,200 blood samples collected from potential blood donors were tested by an …

Background Abnormal remodelling of the extracellular matrix (ECM) has generally been
linked to pulmonary inflammation and fibrosis and may also play a role in the pathogenesis of …

Background T‐cell activation is associated with an adverse outcome in COVID‐19, but whether
T‐cell activation and exhaustion relate to persistent respiratory dysfunction and death is …

People with human immunodeficiency virus (HIV) infection (PWH) have an increased risk of
cardiovascular disease (CVD), compared with the general population. In a nested case-…

Background People with human immunodeficiency virus (PWH) have an increased risk of
chronic lung diseases and chronic inflammation. We aimed to investigate if inflammatory …